ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Secernin-2 Stabilizes Histone Methyltransferase KMT2C to Suppress Progression and Confer Therapeutic Sensitivity to PARP Inhibition in Triple-Negative Breast Cancer.

Min-Ying Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.